Baring International Investment’s AbbVie ABBV Stock Holding History

Baring International Investment’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$6.17M	Sell	109,256 -139,419	-56%	-$7.31M	0.39%	72
2014 Q1	$12.8M	Buy	248,675 +217,465	+697%	+$11M	0.75%	55
2013 Q4	$1.65M	Sell	31,210 -42,085	-57%	-$2.07M	0.09%	107
2013 Q3	$3.28M	Buy	+73,295	New	+$3.25M	0.15%	105

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baring International Investment's ABBV Position: Q2 2014 in Review

Baring International Investment reduced its AbbVie (ABBV) stake by 56% in Q2 2014, selling an estimated $7.31M and leaving 109,256 shares worth $6.17M. The position accounts for 0.39% of the portfolio, ranked #72.

Baring International Investment first reported a position in ABBV in Q3 2013 and has held it in 4 quarters since. The position peaked at $12.8M in Q1 2014. 1,457 funds tracked by Wall St. Rank hold ABBV as of Q2 2014.

Baring International Investment held 109,256 shares of AbbVie worth $6.17M as of Q2 2014.
Baring International Investment sold 139,419 AbbVie shares in Q2 2014, an estimated $7.31M.
AbbVie made up 0.39% of Baring International Investment's portfolio in Q2 2014, its #72 holding.
Baring International Investment first reported a position in AbbVie in Q3 2013 and has held it in 4 quarters since.
Baring International Investment's AbbVie position peaked at $12.8M in Q1 2014.
1,457 funds tracked by Wall St. Rank held AbbVie as of Q2 2014.

Based on Baring International Investment's 13F filing for Q2 2014, filed 21 Jul 2014.